DUBLIN--(BUSINESS WIRE)--The "Tissue Banking Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide.
According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately 60% of all deaths worldwide. The global burden of chronic diseases is expected to reach 57%, by 2020. This trend is expected to affect the emerging countries the most, as population growth is anticipated to be most significant in developing areas. Consequently, rising burden of chronic diseases is expected to drive the overall growth of the tissue banking market. However, stringent regulatory scenario is expected to restrain the growth of the global market in the forecast period.
- AMS Biotechnology (Europe) Limited
- Avantor, Inc (VWR International)
- Sartorius AG
- Brooks Lifesciences (Brooks Automation Inc.)
- Bio-Rad Laboratories Inc.
- Eppendorf AG
- Hamilton Company
- Merck KGaA
- Thermo Fisher Scientific, Inc.
Key Market Trends
Equipment Segment is Expected to Show Better Growth in the Forecast Period
Based on the product, it is segmented into equipment and media and consumables. The equipment segment is expected to grow at a faster pace during the forecast period. The key factor contributing to the growth of the segment is mainly driven by growing research activities and increasing the focus of market players on product development, along with the rising burden of chronic diseases. According to the World Health Organization (WHO), the four major chronic diseases which include cardiovascular diseases followed by cancer, respiratory diseases and diabetes account for most deaths. Factors, such as the aging population, lifestyles changes, leads to long-term health problems, and their treatment can be expensive. Additionally, Increasing government initiatives and rising demand for transplantation is expected to boost the studied market.
North America is Estimated to Account for the Largest Share in the Tissue Banking Market
North America holds a major share in the global tissue banking market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The United States market is driven by increasing R&D activities, along with rising burden of chronic diseases. According to Center for Disease Control and Prevention (CDC), 6 in 10 adults in the United States have a chronic disease. Different pharmaceutical/ biotech companies, academia, and research institutes are utilizing tissue banks for the storage of various samples. Hence, North America region is expected to grow at a faster rate due to rising preclinical activities by pharmaceutical companies, and growing research in this region.
Key Topics Covered:
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Healthcare Expenditure
4.2.2 Growing Burden of Chronic Diseases
4.2.3 Technological Advances in Drug Discovery and Development
4.3 Market Restraints
4.3.1 Stringent Regulatory Scenario
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
22.214.171.124 Cryopreservation Equipment
126.96.36.199 Thawing Equipment
188.8.131.52 Quality Control Equipment
5.1.2 Media and Consumables
5.2 By Application
5.2.2 Medical Research
5.2.3 Other Applications
5.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle-East and Africa
5.3.5 South America
220.127.116.11 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AMS Biotechnology (Europe) Limited
6.1.2 Avantor, Inc (VWR International)
6.1.3 Sartorius AG
6.1.4 Brooks Lifesciences (Brooks Automation Inc.)
6.1.5 Bio-Rad Laboratories Inc.
6.1.6 Eppendorf AG
6.1.7 Hamilton Company
6.1.8 Merck KGaA
6.1.9 Thermo Fisher Scientific, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/4w16v4